Mark A. Hlatky, MD
Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M18-3632.
Corresponding Author: Mark A. Hlatky, MD, Stanford University School of Medicine, HRP Redwood Building, Room T150, 259 Campus Drive, Stanford, CA 94305; e-mail, hlatky@stanford.edu.
Hlatky MA. A Pound of Prevention? Assessing the Value of New Cholesterol-Lowering Drugs. Ann Intern Med. [Epub ahead of print ]:. doi: 10.7326/M18-3632
Download citation file:
© 2019
Published: Ann Intern Med. 2019.
DOI: 10.7326/M18-3632
Cardiology, Coronary Risk Factors, Dyslipidemia.
Results provided by: